TTAB Oppositions 91230516
USPTO Oppositions proceeding 91230516, filed 2016-10-10. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91230516 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2016-10-10 |
| Last Activity | 2016-12-14 |
| Days Active | 3504 |
Parties
- PARI Pharma GmbH — Defendant
- Jazz Pharmaceuticals, Inc. — Plaintiff
Plaintiff Marks
- XYREM — Jazz Pharmaceuticals, Inc.
- XYREM — Jazz Pharmaceuticals, Inc.
- XYREM — Jazz Pharmaceuticals, Inc.
- XYREM — Jazz Pharmaceuticals, Inc.
- XYREM — Jazz Pharmaceuticals, Inc.
- XYREM — Jazz Pharmaceuticals, Inc.
- XYREM — Jazz Pharmaceuticals, Inc.
- XYREM PATIENT SUCCESS PROGRAM — Jazz Pharmaceuticals, Inc.
- XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII — Jazz Pharmaceuticals, Inc.
- XYREM SUCCESS PROGRAM — Jazz Pharmaceuticals, Inc.
- XYREM SUCCESS PROGRAM FOR PHYSICIANS — Jazz Pharmaceuticals, Inc.
Defendant Marks
- ZIRELA — PARI Pharma GmbH
Recent Documents
- 2016-12-14: TERMINATED — Status
- 2016-12-14: BD DECISION: DISMISSED — Decisions
- 2016-12-02: MOT TO AMEND APPLICATION — Motions
- 2016-10-12: SUSPENDED — Status
- 2016-10-12: STIP TO SUSP PEND SETTL NEGOTIATIONS — Motions
- 2016-10-10: PENDING, INSTITUTED — Status
- 2016-10-10: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2016-10-10: FILED AND FEE — Fees